Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
The global Pimozide market was valued at US$ 12 million in 2020 and is expected to reach US$ 10 million by the end of 2029, growing at a CAGR of -0.9% during 2021-2029.
This report focuses on Pimozide volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pimozide market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Pimozide Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
1Mg
2Mg
4Mg
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
1 Pimozide Market Overview
1.1 Product Overview and Scope of Pimozide
1.2 Pimozide Segment by Type
1.2.1 Global Pimozide Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 1Mg
1.2.3 2Mg
1.2.4 4Mg
1.3 Pimozide Segment by Application
1.3.1 Global Pimozide Sales Comparison by Application: (2021-2029)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Pimozide Market Size Estimates and Forecasts
1.4.1 Global Pimozide Revenue 2016-2029
1.4.2 Global Pimozide Sales 2016-2029
1.4.3 Pimozide Market Size by Region: 2016 Versus 2021 Versus 2029
2 Pimozide Market Competition by Manufacturers
2.1 Global Pimozide Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pimozide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pimozide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pimozide Manufacturing Sites, Area Served, Product Type
2.5 Pimozide Market Competitive Situation and Trends
2.5.1 Pimozide Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pimozide Players Market Share by Revenue
2.5.3 Global Pimozide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pimozide Retrospective Market Scenario by Region
3.1 Global Pimozide Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pimozide Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pimozide Market Facts & Figures by Country
3.3.1 North America Pimozide Sales by Country
3.3.2 North America Pimozide Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pimozide Market Facts & Figures by Country
3.4.1 Europe Pimozide Sales by Country
3.4.2 Europe Pimozide Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pimozide Market Facts & Figures by Region
3.5.1 Asia Pacific Pimozide Sales by Region
3.5.2 Asia Pacific Pimozide Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pimozide Market Facts & Figures by Country
3.6.1 Latin America Pimozide Sales by Country
3.6.2 Latin America Pimozide Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pimozide Market Facts & Figures by Country
3.7.1 Middle East and Africa Pimozide Sales by Country
3.7.2 Middle East and Africa Pimozide Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pimozide Historic Market Analysis by Type
4.1 Global Pimozide Sales Market Share by Type (2016-2021)
4.2 Global Pimozide Revenue Market Share by Type (2016-2021)
4.3 Global Pimozide Price by Type (2016-2021)
5 Global Pimozide Historic Market Analysis by Application
5.1 Global Pimozide Sales Market Share by Application (2016-2021)
5.2 Global Pimozide Revenue Market Share by Application (2016-2021)
5.3 Global Pimozide Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Pimozide Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Teva Pimozide Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Par Pharmaceutical
6.2.1 Par Pharmaceutical Corporation Information
6.2.2 Par Pharmaceutical Description and Business Overview
6.2.3 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Par Pharmaceutical Pimozide Product Portfolio
6.2.5 Par Pharmaceutical Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Pimozide Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Eumedica
6.4.1 Eumedica Corporation Information
6.4.2 Eumedica Description and Business Overview
6.4.3 Eumedica Pimozide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eumedica Pimozide Product Portfolio
6.4.5 Eumedica Recent Developments/Updates
6.5 Pharmascience
6.5.1 Pharmascience Corporation Information
6.5.2 Pharmascience Description and Business Overview
6.5.3 Pharmascience Pimozide Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pharmascience Pimozide Product Portfolio
6.5.5 Pharmascience Recent Developments/Updates
6.6 Domina Pharmaceuticals
6.6.1 Domina Pharmaceuticals Corporation Information
6.6.2 Domina Pharmaceuticals Description and Business Overview
6.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Domina Pharmaceuticals Pimozide Product Portfolio
6.6.5 Domina Pharmaceuticals Recent Developments/Updates
6.7 Aa Pharma
6.6.1 Aa Pharma Corporation Information
6.6.2 Aa Pharma Description and Business Overview
6.6.3 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aa Pharma Pimozide Product Portfolio
6.7.5 Aa Pharma Recent Developments/Updates
7 Pimozide Manufacturing Cost Analysis
7.1 Pimozide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pimozide
7.4 Pimozide Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pimozide Distributors List
8.3 Pimozide Customers
9 Pimozide Market Dynamics
9.1 Pimozide Industry Trends
9.2 Pimozide Growth Drivers
9.3 Pimozide Market Challenges
9.4 Pimozide Market Restraints
10 Global Market Forecast
10.1 Pimozide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pimozide by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Pimozide by Type (2022-2029)
10.2 Pimozide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pimozide by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Pimozide by Application (2022-2029)
10.3 Pimozide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pimozide by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Pimozide by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pimozide Sales (K Units) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Pimozide Sales (K Units) Comparison by Application (2021-2029)
Table 3. Global Pimozide Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Pimozide Covered in This Study
Table 5. Global Pimozide Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Pimozide Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pimozide Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pimozide Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pimozide Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pimozide Manufacturing Sites and Area Served
Table 11. Manufacturers Pimozide Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pimozide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pimozide as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pimozide Sales by Region (2016-2021) & (K Units)
Table 16. Global Pimozide Sales Market Share by Region (2016-2021)
Table 17. Global Pimozide Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pimozide Sales by Country (2016-2021) & (K Units)
Table 19. North America Pimozide Sales Market Share by Country (2016-2021)
Table 20. North America Pimozide Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pimozide Revenue Market Share by Country (2016-2021)
Table 22. Europe Pimozide Sales by Country (2016-2021) & (K Units)
Table 23. Europe Pimozide Sales Market Share by Country (2016-2021)
Table 24. Europe Pimozide Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pimozide Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pimozide Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Pimozide Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pimozide Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pimozide Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pimozide Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Pimozide Sales Market Share by Country (2016-2021)
Table 32. Latin America Pimozide Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pimozide Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pimozide Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Pimozide Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pimozide Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pimozide Revenue Market Share by Country (2016-2021)
Table 38. Global Pimozide Sales (K Units) by Type (2016-2021)
Table 39. Global Pimozide Sales Market Share by Type (2016-2021)
Table 40. Global Pimozide Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pimozide Revenue Share by Type (2016-2021)
Table 42. Global Pimozide Price (USD/Unit) by Type (2016-2021)
Table 43. Global Pimozide Sales (K Units) by Application (2016-2021)
Table 44. Global Pimozide Sales Market Share by Application (2016-2021)
Table 45. Global Pimozide Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pimozide Revenue Share by Application (2016-2021)
Table 47. Global Pimozide Price (USD/Unit) by Application (2016-2021)
Table 48. Teva Corporation Information
Table 49. Teva Description and Business Overview
Table 50. Teva Pimozide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Teva Pimozide Product
Table 52. Teva Recent Developments/Updates
Table 53. Par Pharmaceutical Corporation Information
Table 54. Par Pharmaceutical Description and Business Overview
Table 55. Par Pharmaceutical Pimozide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Par Pharmaceutical Pimozide Product
Table 57. Par Pharmaceutical Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Pimozide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Pimozide Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Eumedica Corporation Information
Table 64. Eumedica Description and Business Overview
Table 65. Eumedica Pimozide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Eumedica Pimozide Product
Table 67. Eumedica Recent Developments/Updates
Table 68. Pharmascience Corporation Information
Table 69. Pharmascience Description and Business Overview
Table 70. Pharmascience Pimozide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Pharmascience Pimozide Product
Table 72. Pharmascience Recent Developments/Updates
Table 73. Domina Pharmaceuticals Corporation Information
Table 74. Domina Pharmaceuticals Description and Business Overview
Table 75. Domina Pharmaceuticals Pimozide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Domina Pharmaceuticals Pimozide Product
Table 77. Domina Pharmaceuticals Recent Developments/Updates
Table 78. Aa Pharma Corporation Information
Table 79. Aa Pharma Description and Business Overview
Table 80. Aa Pharma Pimozide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Aa Pharma Pimozide Product
Table 82. Aa Pharma Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Pimozide Distributors List
Table 86. Pimozide Customers List
Table 87. Pimozide Market Trends
Table 88. Pimozide Growth Drivers
Table 89. Pimozide Market Challenges
Table 90. Pimozide Market Restraints
Table 91. Global Pimozide Sales Forecast by Type (2022-2029) & (K Units)
Table 92. Global Pimozide Sales Market Share Forecast by Type (2022-2029)
Table 93. Global Pimozide Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 94. Global Pimozide Revenue Market Share Forecast by Type (2022-2029)
Table 95. Global Pimozide Sales Forecast by Application (2022-2029) & (K Units)
Table 96. Global Pimozide Sales Market Share Forecast by Application (2022-2029)
Table 97. Global Pimozide Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 98. Global Pimozide Revenue Market Share Forecast by Application (2022-2029)
Table 99. Global Pimozide Sales Forecast by Region (2022-2029) & (K Units)
Table 100. Global Pimozide Sales Market Share Forecast by Region (2022-2029)
Table 101. Global Pimozide Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 102. Global Pimozide Revenue Market Share Forecast by Region (2022-2029)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pimozide
Figure 2. Global Pimozide Market Share by Type in 2020 & 2029
Figure 3. 1Mg Product Picture
Figure 4. 2Mg Product Picture
Figure 5. 4Mg Product Picture
Figure 6. Global Pimozide Market Share by Application in 2020 & 2029
Figure 7. Hospitals
Figure 8. Drugstores
Figure 9. Others
Figure 10. Global Pimozide Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 11. Global Pimozide Market Size 2016-2029 (US$ Million)
Figure 12. Global Pimozide Sales 2016-2029 (K Units)
Figure 13. Global Pimozide Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 14. Pimozide Sales Share by Manufacturers in 2020
Figure 15. Global Pimozide Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Pimozide Players: Market Share by Revenue in 2020
Figure 17. Pimozide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Pimozide Sales Market Share by Region (2016-2021)
Figure 19. Global Pimozide Sales Market Share by Region in 2020
Figure 20. Global Pimozide Revenue Market Share by Region (2016-2021)
Figure 21. Global Pimozide Revenue Market Share by Region in 2020
Figure 22. U.S. Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Pimozide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Pimozide by Type (2016-2021)
Figure 47. Sales Market Share of Pimozide by Application (2016-2021)
Figure 48. Sales Market Share of Pimozide by Application in 2020
Figure 49. Revenue Share of Pimozide by Application (2016-2021)
Figure 50. Revenue Share of Pimozide by Application in 2020
Figure 51. Manufacturing Cost Structure of Pimozide
Figure 52. Manufacturing Process Analysis of Pimozide
Figure 53. Pimozide Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
